Anti-Müllerian Hormone (AMH)

Anti-Müllerian Hormone (AMH) is a hormone produced by specialised cells within the ovaries. It indicates ovarian reserve, which refers to the quantity and quality of a woman’s remaining eggs. AMH levels are typically measured through a blood test and provide valuable information about a woman’s fertility potential. Higher levels of AMH usually indicate a more significant number of eggs in the ovaries, while lower levels may suggest diminished ovarian reserve. AMH testing is commonly used in fertility assessments, particularly for women undergoing in vitro fertilisation (IVF) or other assisted reproductive techniques. It helps doctors tailor treatment approaches, predict the response to ovarian stimulation medications, and estimate the chances of success in fertility treatments. Additionally, AMH levels can be informative for women considering fertility preservation or those with conditions that might impact their ovarian function. However, it is essential to interpret AMH results with other clinical factors, as individual variations exist, and multiple factors contribute to a woman’s fertility journey.